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Abstract: The purpose of the present study was to examine the combined effects of aging 
and lifelong ethanol exposure on the levels of monoamine neurotransmitters in different 
regions of the brain. This work is part of a project addressing interactions of aging and 
lifelong ethanol consumption in alcohol-preferring AA (Alko Alcohol) line of rats, selected 
for high voluntary consumption of ethanol. Intake of ethanol on the level of 4.5–5 g/kg/day 
for about 20 months induced only limited changes in the neurotransmitter levels; the 
concentration of noradrenaline was significantly reduced in the frontal cortex. There was 
also a trend towards lower levels of dopamine and 5-hydroxytryptamine (5-HT) in the 
frontal cortex, and towards a lower noradrenaline level in the dorsal cortex. Aging was 
associated with a decreased concentration of dopamine in the dorsal cortex and with a 
declining trend in the striatum. The levels of 5-HT in the limbic forebrain were higher in 
the aged than in the young animals, and in the striatum, there was a trend towards higher 
levels in older animals. The data suggest that a continuous intake of moderate amounts of 
ethanol does not enhance the age-related alterations in brain monoamine neurotransmission, 
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while the decline in the brain level of dopamine associated with aging may be a factor 
contributing to age-related neurological disorders. 
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Abbreviations 
AA: Alko Alcohol, alcohol-preferring rat line; ANA: Alko Non-Alcohol, alcohol-avoiding rat line; 
CNS: central nervous system; HPLC: high performance liquid chromatography; i.p.: intraperitoneal; 
n.s.: non-significant; SEM: standard error of the mean; 5-HT: 5-hydroxytryptamine 
1. Introduction 
Both aging and chronic ethanol consumption are associated with several deficits in the brain. The 
impairments of cognitive and motor function have been linked with a number of deleterious 
morphological and functional changes involving different areas of the central nervous system (CNS). 
The contribution of aging and chronic ethanol consumption to the development of deficits may be 
separate or combined. The interactions of aging and chronic ethanol exposure have, however, been 
addressed in relatively few studies.  
Age-related deficits in motor and cognitive function have been attributed to impairment of 
monoaminergic neurotransmission [1,2]. Several studies have demonstrated selective changes in the 
concentration of noradrenaline, dopamine and 5-HT in different areas of rat CNS during aging [3–7]. 
Studies conducted with the mutant zitter rats have demonstrated age-related degenerative changes in 
the different terminal areas of the ascending dopaminergic and 5-hydroxytryptaminergic neuronal 
systems [6,8]. Moreover, age-dependent decreases in the neuronal density of some noradrenergic 
projection areas in the forebrain have been observed in immunohistochemical studies [9]. Age-related 
decline in dopamine D1 and D2 receptors in the nigrostriatal and mesocorticolimbic systems as well as 
in striatal dopamine transporter density have also been observed [10–12]. The dopamine release 
mechanism in the striatum, however, seems to remain unaffected in aged animals [13]. 
Previous studies on the interactions of aging and chronic ethanol exposure suggests that the  
age-related decline in monoaminergic functions is not drastically enhanced by ethanol. Administration 
of ethanol for six weeks was not found to accentuate the age-related loss of dopamine D2 receptors [11]. 
Human type 2 alcoholics showed similar decline in the density of dopamine transporter as the  
controls [12]. A remarkable sensitivity to ethanol-induced degeneration was, however, detected in the 
locus coeruleus, the major source of noradrenergic projections to almost every region of the brain; 
locus coeruleus neuron numbers decreased significantly in AA and ANA rats after lifelong ethanol 
exposure, while no age-related locus coeruleus neuron loss was seen in the control groups up to 2 years 
of age [14,15]. Furthermore, ethanol consumption was found to reduce GABAA receptor subunit 
expression in a selective manner [16]. 
The purpose of the present study was to examine further the combined effects of aging and lifelong 
exposure to ethanol on the levels of monoamine neurotransmitters in different regions of the brain. 
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Since age-related changes in the metabolism and distribution of ethanol in the body can be a 
contributing factor to ethanol-induced damage, the levels of ethanol and acetaldehyde in the blood 
were also measured. This work is part of a project addressing the interactions of aging and lifelong 
ethanol consumption in the alcohol-preferring AA and the alcohol-avoiding ANA line of rats, selected 
for high and low ethanol consumption, respectively [14–24].  
2. Material and Methods 
2.1. Animals and Treatments 
The animal model used and the protocol for ethanol administration have been described in detail in 
previous studies [22–24]. In this part of the study 15 male and 16 female rats of the alcohol-preferring 
AA line from generation F67, and 5 male and 5 female rats from the generation F71 were used. The rats 
were housed in group cages (4–5 animals per cage) under standard conditions with a free access to 
standard rat food (RM1(E)SQC, SDS, Witham, UK). The experimental procedures were approved by 
the Institutional Animal Care and Use Committee at Alko Group Ltd. (Helsinki, Finland).  
The AA rats from generation F67 were randomly assigned to the old ethanol group (n = 19) and the 
old control group (n = 12). Voluntary ethanol consumption of the animals was measured at the age of  
3 months, and again at the age of 24 months, by offering a free choice between water and 10% (v/v) 
ethanol in individual cages for 3 weeks [22]. Between these free-choice periods, the ethanol group was 
given 10%–12% ethanol as the only source of fluid (10% ethanol for one month, 12% ethanol 
thereafter), while the controls were given water. Consumption of ethanol when it was available as the 
only source of fluid (forced ethanol consumption) was determined in both groups at the age of  
23 months. The animals of the young control group came from generation F71 (n = 10). They had free 
access to food and water throughout the experiment.  
2.2. Determination of Concentrations of Ethanol and Acetaldehyde in the Blood 
Concentrations of ethanol and acetaldehyde in the blood were measured before and after the 
administration of ethanol 1 g/kg i.p. (12% w/v in saline) in both the ethanol group and the control 
group at the age of 12 months. Blood samples of 50 µL were taken from the tip of the tail immediately 
before (0 min) as well as 60 and 120 min after administration of ethanol. The blood hemolysates were 
stored at −20 °C until analysis with headspace gas chromatography [25,26]. The rate of ethanol 
metabolism was also calculated [25]. 
2.3. Assay of Monoamines in Brain Tissue 
At the age of 24 months, after a one-week ethanol-free washout period, the rats were decapitated 
under deep sodium pentobarbital anaesthesia. The brains were immediately removed from the skull 
and dissected on ice into the dorsal part of the cerebral cortex, the frontal cortex, the striatum, the 
limbic forebrain (containing tuberculum olfactorium, nucleus accumbens and septum), the 
hippocampus, the hypothalamus, and the cerebellum. The tissue samples were frozen on dry ice and 
stored at −75 °C. The concentration of noradrenaline, dopamine, and 5-HT were measured by high 
performance liquid chromatography (HPLC), as described in detail previously [27]. 
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2.4. Statistics 
The normally distributed data on body weights and ethanol consumption are expressed as  
mean ± SEM. The monoamine, ethanol and acetaldehyde concentrations are given as median (min, 
max). The overall differences in brain monoamine concentrations were analyzed by using the  
non-parametric Kruskal-Wallis test, followed by the Conover-Inman test (young control vs. old 
control, old control vs. ethanol). Student’s t-test was used to compare body weights and ethanol 
consumption between the old control and the ethanol-exposed group, while the concentrations of 
acetaldehyde and ethanol and the metabolism of these were tested with the Mann-Whitney U test. 
3. Results and Discussion 
3.1. Body Weight and Ethanol Consumption 
At the beginning of the experiment the body weights of the groups were similar; 286 ± 19 g in the 
ethanol group and 256 ± 28 g in the control group. The body weights increased significantly over age. 
The rats in the ethanol group tended to be heavier than the controls at the age of 12 (447 ± 35 g and 
349 ± 45 g, n.s.) and 23 months (521 ± 40 and 433 ± 52 g, n.s.). 
Voluntary consumption of ethanol at the age of 3 or 24 months did not differ significantly between 
the control group and the ethanol group (Table 1). There was no difference in forced ethanol 
consumption, either. Ethanol consumption in the present cohort of animals was essentially similar to 
that described in our previous reports [22–24].  
Table 1. Consumption of ethanol (g/kg/day) during different phases of the experiment. 
Group (n) 
Voluntary consumption 
Age 3 months 
Forced consumption  
Age 23 months 
Voluntary consumption  
Age 24 months 
Control (8) 5.3 ± 0.8 5.0 ± 0.6 5.5 ± 0.7 
Ethanol (15) 5.2 ± 0.4 4.6 ± 0.4 4.7 ± 0.4 
Mean daily consumption of ethanol as g of absolute ethanol/kg of body weight ± SEM. Apart from the  
3-week test periods at the beginning and at the end of the experiment, the ethanol-exposed group had  
10%–12% ethanol as the only source of fluid, while the control group was given only water to drink. 
3.2. Concentrations of Ethanol and Acetaldehyde  
The blood concentrations of ethanol and acetaldehyde were significantly higher in the  
ethanol-exposed group than in the controls at time point 0 min, i.e., before the administration of 
ethanol, because the rats in the ethanol group had consumed ethanol during the night before, and all 
ethanol and acetaldehyde had not been metabolized (Table 2). The rates of ethanol and acetaldehyde 
metabolism, which virtually are the same, because of the high efficiency of acetaldehyde  
oxidation [28], were significantly higher in the ethanol group than in the control group.  
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Table 2. Concentrations and elimination rates of ethanol and acetaldehyde at 12 months of 
age in the controls and in the ethanol-exposed group. 
Group Ethanol (mM) Acetaldehyde (µM) 
(n) 0 min 60 min 120 min Δ 0 min 60 min 120 min 
Control  
(7–8) 
0  
(0; 0.1) 
20  
(9.7; 31) 
8.6  
(1.5; 22) 
9.6 
0  
(0; 0.3) 
1.3  
(1; 2.1) 
1.2  
(0.6; 2.1) 
Ethanol  
(14) 
0.3  
(0; 6.9) ** 
21.2  
(11; 31.3) 
8.7  
(2; 15.7) 
12.2 * 
1.4  
(0; 8.4) *** 
2.4  
(1; 11.3) * 
2  
(0.6; 10.6) 
* p < 0.05; ** p < 0.01; *** p < 0.001, relative to the control group, Mann-Whitney U test; median, (min; 
max) are given. Δ elimination rates of ethanol and acetaldehyde were both estimated from the change in the 
ethanol concentrations between the 60 min and 120 min measurements. 
3.3. Concentrations of Monoamines 
The concentrations of monoamine transmitters in different areas of the brain are presented in  
Table 3. As gender had no effect on the monoamine concentrations, results from the male and female 
rats were pooled together. Both aging and ethanol induced selective alterations in regional monoamine 
concentrations. Aging was associated with a reduced concentration of dopamine in the dorsal cortex 
and an increased concentration of 5-HT in the limbic forebrain. Significant ethanol-induced alterations 
were found only in the frontal cortex, where the concentration of noradrenaline was lower in the 
ethanol rats than in the control rats.  
3.4. Discussion 
The present study addressed the interaction of aging and lifelong ethanol consumption on the CNS 
concentrations of monoamine neurotransmitters in the alcohol-preferring AA rats. The underlying idea 
was to test, whether chronic ethanol consumption enhances the age-related changes in the CNS, as has 
been hypothesized [29,30]. The AA rats consumed ca. 4.5–5 g of ethanol/kg/day for 20 months, and 
the rate of ethanol and subsequent acetaldehyde elimination were significantly increased in the ethanol 
consuming animals, probably as a result of chronic exposure to ethanol. The AA rats acquire a high 
level of voluntary ethanol intake in about three weeks, when given a free access to ethanol solution 
with water and food freely available [24]. In earlier studies, lifelong consumption of ethanol by AA 
rats has been found to increase the behavioral sensitivity to ethanol over age and to produce 
morphological changes in peripheral sympathetic neurons and cerebellar cortex, as well as molecular 
alterations in brain GABAA receptor subunits [14–22].  
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Table 3. Concentrations of monoamines in different brain areas of young control, old 
control, and old ethanol-exposed AA rats. 
 Young control Old control Old ethanol 
Frontal Cortex       
 Noradrenaline 3.88 1.97; 4.30 (9) 3.96 2.90; 4.52 (8) 3.26 2.57; 4.03 (13) * 
 Dopamine 1.37 0.66; 2.19 (8) 1.56 0.45; 3.40 (8) 0.81 0.58; 2.22 (11) 
 5-HT 1.06 0.53; 2.32 (9) 1.18 0.29; 2.01 (8) 0.78 0.42; 1.34 (13) 
Dorsal Cortex       
 Noradrenaline 4.34 1.95; 5.80 (9) 3.28 2.83; 4.41 (8) 2.54 2.08; 5.07 (13) 
 Dopamine 0.26 0.10; 0.64 (8) 0.10 0.04; 0.32 (8) # 0.09 0.04; 0.36 (13) 
 5-HT 0.24 0.15; 0.35 (9) 0.21 0.10; 0.39 (8) 0.19 0.12; 0.25 (13) 
Hippocampus       
 Noradrenaline 4.33 3.18; 6.54 (9) 3.96 3.24; 5.07 (8) 3.67 3.00; 4.69 (13) 
 Dopamine 0.13 0.07; 0.38 (8) 0.24 0.07; 0.33 (7) 0.22 0.07; 0.57 (12) 
 5-HT 0.04 0.04; 0.05 (9) 0.05 0.03; 0.06 (7) 0.04 0.03; 0.06 (11) 
Striatum       
 Noradrenaline 2.15 1.48; 2.82 (9) 1.95 1.37; 3.63 (8) 1.87 1.44; 2.41 (13) 
 Dopamine 75.93 41.67; 90.00 (9) 64.30 50.51; 83.98 (8) 60.20 37.67; 75.54 (13) 
 5-HT 0.17 0.08; 2.21 (7) 1.04 0.12; 2.21 (6) 1.32 0.18; 2.30 (10) 
Limbic Forebrain       
 Noradrenaline 7.38 3.67; 8.28 (8) 7.70 5.93; 9.66 (8) 6.90 4.37; 8.54 (13) 
 Dopamine 28.85 18.50; 41.49 (9) 27.44 23.91; 40.37 (8) 28.61 23.85; 36.70 (13) 
 5-HT 3.10 1.38; 6.91 (9) 12.45 1.70; 13.12 (8) # 8.93 2.14; 13.04 (13) 
Hypothalamus       
 Noradrenaline 13.77 7.02; 20.62 (9) 13.47 8.74; 19.82 (8) 14.58 11.87; 19.19 (12) 
 Dopamine 2.37 1.88; 4.23 (9) 2.74 2.11; 3.28 (8) 2.70 1.83; 3.98 (13) 
 5-HT 3.23 1.74; 3.81 (8) 3.31 2.69; 6.53 (7) 3.42 2.36; 5.66 (12) 
Cerebellum       
 Noradrenaline 2.39 1.36; 2.60 (9) 2.24 1.97; 3.01 (8) 2.55 1.88; 3.05 (13) 
 Dopamine 0.04 0.02; 0.07 (9) 0.06 0.04; 0.06 (7) 0.05 0.04; 0.07 (12) 
 5-HT 0.06 0.04; 0.09 (9) 0.06 0.03; 0.07 (8) 0.05 0.04; 0.07 (13) 
The concentrations are given in nmol/g tissue, median (min, max). * p < 0.05, Old ethanol vs. Old control group;  
# p < 0.05, Old control vs. Young control group; 5-HT: 5-hydroxytryptamine. 
Earlier studies on monoamine neurotransmitters have revealed higher brain levels of dopamine and 
noradrenaline in the AA rats than in the alcohol-avoiding ANA rats [24]. The dopaminergic systems in 
the AA and ANA rats do not, however, differ in their sensitivity to ethanol. In the present study, the 
lifelong ethanol treatment induced only limited changes in the monoamine neurotransmitter levels; the 
concentration of noradrenaline was significantly reduced in the frontal cortex. There was also a trend 
(n.s.) towards lower levels of noradrenaline in the dorsal cortex, as well as those of dopamine and  
5-HT in the frontal cortex of the ethanol-exposed animals. These results are in line with our earlier 
findings based on a similar experimental protocol, showing that lifelong ethanol intake was associated 
with a 26%–30% decrease in the neuron number of the locus coeruleus, the major source of 
noradrenaline in the CNS [14,15]. In other studies it has been reported that treatment with ethanol for 
six weeks did not enhance the age-related loss of dopamine D2 receptors in rats, and that the  
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age-related decline in the density of dopamine transporter in human type 2 alcoholics was similar to 
the controls [11,12]. These data may indicate that noradrenergic neurotransmission is more sensitive to 
ethanol-induced degeneration than the dopaminergic or 5-hydroxytryptaminergic ones. 
The level of ethanol consumption reached in the present study was estimated to result in peak 
nocturnal blood ethanol levels of about 10–20 mM, which can be considered intoxicating [31,32]. The 
neurotoxicity of ethanol in this kind of continuous exposure to moderate concentrations of ethanol 
seems to be rather limited—both quantitatively and regionally. It is possible that an intermittent 
exposure to ethanol could have resulted in more extensive alterations in CNS monoamine 
neurotransmission, as repeated withdrawal phases have been suggested to be more deleterious to 
neurons than chronic ethanol exposure per se [33–35]. Intermittent ethanol exposure (5.8 g/kg/day four 
days a week for 5.5 months) was previously found to induce significant loss of noradrenergic neurons 
in rat superior cervical ganglion, while no neuron loss occurred in rats exposed to similar amounts of 
ethanol continuously [36]. Moreover, loss of locus coeruleus noradrenergic neurons was seen in aged 
rats (29–30 months old) after only 5 weeks of intermittent exposure to heavily intoxicating doses  
of ethanol [37]. On the other hand, formation of acetaldehyde adducts, possible mediators of  
ethanol-induced toxicity, was reported in the frontal cortex and cerebellum of AA and ANA rats given 
a continuous ethanol treatment similar to the present one [20]. Selective volume loss of the anterior 
superior cerebellar vermis was also found after lifelong, continuous ethanol exposure [19]. 
Aging was associated with a decreased concentration of dopamine in the dorsal cortex and with a 
declining trend in the striatum. The results are in line with earlier reports showing reduced 
concentrations of dopamine in the brain of aged rats, especially in the dopamine rich areas [3–5,7]. 
They are also consistent with investigations reporting age-related decline in dopamine D1 and D2 
receptors [10,11]. These findings together support the view that a reduction in dopaminergic neuronal 
functions contributes to age-related neurological manifestations, e.g. movement disorders [1,38].  
In the old control group, the concentration of 5-HT in the limbic forebrain was higher than in the 
young animals, and in the striatum there was a trend towards higher levels in the old controls. The data 
on 5-HT reported in the literature are, however, somewhat conflicting. In a study by Woods and  
Druse [4], an age-related increase in 5-HT turnover was observed, which is probably consistent with 
the present data. In contrast with these findings, reduced levels of 5-HT have been reported in several 
brain regions in aged rats [5,7]. Therefore, the role of 5-HT in the mechanisms of aging and the  
age-related impairment of CNS functions remain to be clarified. 
There were no significant alterations with aging in the brain levels of noradrenaline. These data are 
consistent with the study by Míguez and others [5], where the concentration of noradrenaline remained 
unchanged with aging in several brain areas and was significantly reduced only in the pons-medulla. 
On the other hand, decreased levels of noradrenaline, as well as reduced density of noradrenergic 
axons and varicosities, have also been reported in aged rats [7,9].  
4. Conclusions  
The present study addressed the combined effects of aging and chronic ethanol consumption on 
brain monoamine neurotransmitters using the alcohol-preferring AA line of rats as a model. The results 
showed that lifelong, continuous consumption of mildly intoxicating amounts of ethanol induced only 
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modest and regionally selective changes in the monoamine neurotransmitter levels. These results along 
with previous data suggest that chronic intake of moderate amounts of ethanol does not potentiate the 
age-related alterations in neuronal structure and functions, but ethanol-induced neuronal changes are 
essentially different from those associated with aging. Age-related decline in the brain dopamine 
concentration supported the idea of dopaminergic neuronal functions contributing to age-related 
neurological dysfunction, e.g., impaired control of movement and posture. 
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